{"id":"W4310107771","doi":"10.1182/blood-2022-167581","title":"Risk Factor Analysis for Second Treatment-Free Remission Failure from the Canadian TKI Discontinuation (TRAD) Trial in CML Patients: Treatment-Free Remission Accomplished By Dasatinib","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; McGill University; London Health Sciences Centre; University of Manitoba; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital de l'Enfant-Jésus; Hôpital Maisonneuve-Rosemont; Nova Scotia Health Authority; Princess Margaret Cancer Centre; University of Calgary; Alberta Health Services; University of Alberta Hospital; Ottawa Hospital; University Health Network; University of Toronto; Alberta Hospital Edmonton; University of British Columbia","funders":"","keywords":"Discontinuation; Dasatinib; Medicine; Internal medicine; Complete remission; Oncology; Surgery; Imatinib; Chemotherapy; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003044873,0.0005316956,0.0009408933,0.0004099585,0.000604625,0.0008908933,0.0009188324,0.000850238,0.003578787],"category_scores_gemma":[0.00342563,0.0001779028,0.0020649,0.000823079,0.0003799666,0.0004078366,0.0006131215,0.001373694,0.0001796938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001419905,"about_ca_system_score_gemma":0.003397844,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01749721,"about_ca_topic_score_gemma":0.02883273,"domain_scores_codex":[0.9979033,0.000657514,0.0001560143,0.000399115,0.0004490082,0.0004351667],"domain_scores_gemma":[0.9962949,0.001088813,0.00115761,0.0002534059,0.0002377012,0.0009675178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1146882,0.0003675133,0.8631313,0.0002621545,0.002558437,0.0002487436,0.0001039025,0.00103612,0.001387533,0.0003373866,0.002865359,0.01301339],"study_design_scores_gemma":[0.006566958,0.00686001,0.9756125,0.00005735618,0.00238236,0.0003999633,0.0001533203,0.002863728,0.0004729671,0.0003406342,0.004228041,0.0000621104],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994298,0.0013748,0.0002094404,0.0002409748,0.00003679221,0.0002331602,0.002122442,0.000009755337,0.001474795],"genre_scores_gemma":[0.9970067,0.0001456313,0.000203452,0.000120463,0.00005506886,0.0001959495,0.001815268,0.000006476972,0.0004510516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9825028,"threshold_uncertainty_score":0.03479075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01854564920350301,"score_gpt":0.2556965387667733,"score_spread":0.2371508895632703,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}